Invest now
Alembic Pharmaceuticals Profit & Loss Annual
BSE: 533573 | NSE: APLLTD | ISIN: INE901L01018 | Sector: Biotechnology & Drugs821.00 -8.65 (-1.04%)Updated : 10 Aug 2026
Research on
| Fiscal Period | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Period End Date | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
| Total Operating Expense | 6,608.85 | 5,929.40 | 5,567.90 | 5,214.84 |
| Other Net | 2.88 | 8.32 | 2.39 | 1.61 |
| Diluted Weighted Average Shares | 19.66 | 19.66 | 19.66 | 19.66 |
| Gain( Loss)on Saleof Assets | -2.17 | 3.26 | 1.70 | -4.70 |
| Depreciation/ Amortization | 318.55 | 278.58 | 272.67 | 275.43 |
| Operating Income | 736.05 | 742.68 | 660.73 | 437.78 |
| Net Income | 674.77 | 583.42 | 615.83 | 341.98 |
| Income Availableto Com Excl Extra Ord | 674.77 | 583.42 | 615.82 | 341.99 |
| Other Operating Expenses Total | 43.21 | 26.07 | 21.40 | 17.57 |
| Net Income Before Taxes | 693.95 | 707.18 | 631.83 | 354.59 |
| Minority Interest | 3.94 | 1.41 | - | - |
| Net Income After Taxes | 670.83 | 582.01 | 615.83 | 341.98 |
| Income Availableto Com Incl Extra Ord | 674.77 | 583.42 | 615.82 | 341.99 |
| Costof Revenue Total | 2,537.24 | 2,316.60 | 2,174.07 | 2,174.70 |
| Gross Profit | 4,807.66 | 4,355.48 | 4,054.56 | 3,477.92 |
| Interest Inc( Exp) Net- Non- Op Total | -42.81 | -47.08 | -32.99 | -80.10 |
| Unusual Expense( Income) | 66.99 | -12.87 | 0.00 | 0.00 |
| Diluted Net Income | 674.77 | 583.42 | 615.82 | 341.99 |
| DPS- Common Stock Primary Issue | 12.00 | 11.00 | 11.00 | 8.00 |
| Provisionfor Income Taxes | 23.12 | 125.17 | 16.00 | 12.61 |
| period Type | - | - | - | - |
| Net Income Before Extra Items | 674.77 | 583.42 | 615.83 | 341.98 |
| Total Revenue | 7,344.90 | 6,672.08 | 6,228.63 | 5,652.62 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Revenue | 7,344.90 | 6,672.08 | 6,228.63 | 5,652.62 |
| Selling/ General/ Admin Expenses Total | 3,065.45 | 2,940.80 | 2,713.01 | 2,178.21 |
| Diluted Normalized EPS | 37.73 | 29.01 | 31.25 | 17.63 |
| Research Development | 577.41 | 380.22 | 386.75 | 568.93 |
| Diluted EPS Excluding Extra Ord Items | 34.33 | 29.68 | 31.33 | 17.40 |
| Total Adjustmentsto Net Income | - | - | -0.10 | 0.10 |
*All figures in crores except per share values
Alembic Pharmaceuticals Quick Links
Alembic Pharmaceuticals Dividend Alembic Pharmaceuticals Bonus Alembic Pharmaceuticals News Alembic Pharmaceuticals AGM Alembic Pharmaceuticals Rights Alembic Pharmaceuticals Splits Alembic Pharmaceuticals Board Meetings Alembic Pharmaceuticals Key Metrics Alembic Pharmaceuticals Shareholdings Alembic Pharmaceuticals Balance Sheet Alembic Pharmaceuticals Cashflow Alembic Pharmaceuticals Q1 Results Alembic Pharmaceuticals Q2 Results Alembic Pharmaceuticals Q3 Results Alembic Pharmaceuticals Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
5,098.20+155.20(3.14%)
1,102.85+20.85(1.93%)
2,024.95+23.05(1.15%)
1,072.00-24.05 (-2.19%)
310.50-4.95 (-1.57%)
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.